{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:33:18Z","timestamp":1793806398948,"version":"4.6.1"},"reference-count":49,"publisher":"American Society for Clinical Investigation","issue":"9","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["TA 1154\/1-1,HE 5208\/2-1,HE 5208\/2-3"],"award-info":[{"award-number":["TA 1154\/1-1,HE 5208\/2-1,HE 5208\/2-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,2]]},"abstract":"<jats:p>Breast cancer bone metastases often cause a debilitating incurable condition with osteolytic lesions, muscle weakness, and a high mortality. Current treatment comprises chemotherapy, irradiation, surgery, and antiresorptive drugs that restrict but do not revert bone destruction. In hormone receptor\u2013negative breast cancer cell lines and human breast cancer tissue, we identified the expression of sclerostin, a soluble Wnt inhibitor that represses osteoblast differentiation and bone formation. In mice with breast cancer bone metastases, pharmacological inhibition of sclerostin using an anti-sclerostin antibody (Scl-Ab) reduced the metastatic burden. Furthermore, sclerostin inhibition prevented cancer-induced bone destruction by augmenting osteoblast-mediated bone formation and by reducing osteoclast-dependent bone resorption. During advanced disease, NF-\u03baB and p38 signaling was increased in muscles in a TGF-\u03b21\u2013dependent manner, causing muscle fiber atrophy, muscle weakness, and tissue regeneration with an increase in Pax7-positive satellite cells. Scl-Ab treatment restored NF-\u03baB and p38 signaling, the abundance of Pax7-positive cells, and muscle function. These effects improved the health and expanded the life span of cancer-bearing mice. Together, these results demonstrate that pharmacological inhibition of sclerostin reduces bone metastatic burden and muscle weakness, with a prolongation of survival time. This might provide novel options for treating musculoskeletal complications in breast cancer patients.<\/jats:p>","DOI":"10.1172\/jci.insight.125543","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:25:55Z","timestamp":1554834355000},"source":"Crossref","is-referenced-by-count":96,"title":["Sclerostin inhibition alleviates breast cancer\u2013induced bone metastases and muscle weakness"],"prefix":"10.1172","volume":"4","author":[{"given":"Eric","family":"Hesse","sequence":"first","affiliation":[{"name":"Molecular Skeletal Biology Laboratory, Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."},{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Schr\u00f6der","sequence":"additional","affiliation":[{"name":"Molecular Skeletal Biology Laboratory, Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Brandt","sequence":"additional","affiliation":[{"name":"Molecular Skeletal Biology Laboratory, Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Pamperin","sequence":"additional","affiliation":[{"name":"Molecular Skeletal Biology Laboratory, Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Saito","sequence":"additional","affiliation":[{"name":"Molecular Skeletal Biology Laboratory, Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8254-9333","authenticated-orcid":true,"given":"Hanna","family":"Taipaleenm\u00e4ki","sequence":"additional","affiliation":[{"name":"Molecular Skeletal Biology Laboratory, Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1370"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030831"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.04.003"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399408000616","article-title":"Molecular mechanisms and treatment of bone metastasis","volume":"10","author":"Clines","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3055"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2781"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7101"},{"issue":"8","key":"B8","first-page":"695","article-title":"Impact of bone-targeted treatments on skeletal morbidity and survival in breast cancer","volume":"30","author":"Coleman","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0600"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2332"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3074"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.5"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305224"},{"issue":"5\u20136","key":"B14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1759720X18775936","article-title":"The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis","volume":"10","author":"S\u00f8lling","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00728-X"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3143"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3961"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1590"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23625"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1158"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7150\/jca.18457"},{"issue":"1-2","key":"B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/BD-2010-0307","article-title":"Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer","volume":"32","author":"Chavez","year":"2010","journal-title":"Breast Dis"},{"issue":"5\u20136","key":"B23","first-page":"707","article-title":"Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6","volume":"79","year":"1999","journal-title":"Br J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609509200"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013444"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1086\/338450"},{"issue":"26","key":"B27","first-page":"3452","volume":"129","author":"McDonald","year":"2017","journal-title":"Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myelomaBlood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2011.063321"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI68523"},{"key":"B30","article-title":"Osteolytic breast cancer causes skeletal muscle weakness in an immunocompetent syngeneic mouse model","volume":"8","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"B31","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/leu.2017.152","article-title":"Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth","volume":"31","year":"2017","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11913-7"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.405456"},{"issue":"17","key":"B34","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"B35","first-page":"97","article-title":"Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment. Curr. Opin","volume":"31","author":"Gu","year":"2016","journal-title":"Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607948"},{"issue":"4","key":"B37","first-page":"396","article-title":"Romosozumab treatment in postmenopausal osteoporosis","volume":"376","author":"Cosman","year":"2017","journal-title":"N Engl J Med"},{"key":"B38"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/1758834017698643"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1242\/dev.067587"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.07.004"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3265"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200408066"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2001.91.2.534"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1026"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.141"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2015.101","article-title":"Assessment of muscle mass and strength in mice","volume":"4","author":"Bonetto","year":"2015","journal-title":"Bonekey Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1805"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/125543\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:30:49Z","timestamp":1779193849000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/125543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,5,2]]},"published-print":{"date-parts":[[2019,5,2]]}},"alternative-id":["10.1172\/jci.insight.125543"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.125543","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"article-number":"e125543"}}